Moneycontrol PRO
LAMF
LAMF

Ranbaxy Laboratories

Jump to
  • Book review: ‘Bottle of Lies’ explores Ranbaxy and the unethical underbelly of Indian pharma

  • ED raids premises of former Ranbaxy group promoters under PMLA

  • Withdraw nod for 28 drug applications of Ranbaxy: Sun Pharma

  • Pharma crusader Thakur takes India's drug regulators to court

  • Sun Pharma gets CCI nod to sell two CNS divisions to Strides

  • Sun Pharma recalls over 10 lakh boxes of allergy drug in US

  • Lupin may test Rs 2600-2700: Prakash Diwan

  • Positive on Sun Pharma, Strides Arcolab: Deepak Shenoy

  • Here are Deepak Shenoy's few trading ideas

  • Fortis's Shivinder Singh steps down to join a spiritual org

  • Strides Arcolab jumps 4%, acquires Sun Pharma's CNS biz

  • Sun Pharma, IDFC, SKS Micro make it to top 10 stocks

  • Sun to sell Ranbaxy's 2 divisions to Strides for Rs 165 cr

  • Sun Pharma to sell facility in Ireland

  • Like private banks, selective pharma, TCS, Infosys: Angel

  • Like Sun Pharma, Strides Arcolab: Deepak Shenoy

  • Rupee fall to help pharma cos; top pick Lupin : JM Fin

  • Sun Pharma up 5%; BoAML upgrades to buy, weak rupee to aid

  • Like Sun Pharma, Granules India, Suven Life: Devang Mehta

  • Sun Pharma Q1 profit tanks 46% on Ranbaxy integration cost

  • Pharma's open offer for Zenotech stake gets tepid response

  • What took mighty Lupin down!

  • Wait 2-3 qtrs to buy Lupin, Sun Pharma: Prabhudas Lilladher

  • Buy Sun Pharma for long term: Kunj Bansal

  • Here are some top trading ideas from Kunj Bansal

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347